ANIKA THERAPEUTICS INC's ticker is ANIK and the CUSIP is 035255108. A total of 160 filers reported holding ANIKA THERAPEUTICS INC in Q1 2016. The put-call ratio across all filers is 0.70 and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2016 | $1,276,000 | +13.4% | 23,783 | -5.4% | 0.19% | +9.1% |
Q1 2016 | $1,125,000 | +9.1% | 25,146 | +13.0% | 0.18% | -10.2% |
Q2 2014 | $1,031,000 | -23.8% | 22,245 | -32.4% | 0.20% | -19.7% |
Q1 2014 | $1,353,000 | -6.6% | 32,915 | -13.3% | 0.24% | -5.8% |
Q4 2013 | $1,448,000 | +59.1% | 37,955 | -0.1% | 0.26% | +43.1% |
Q3 2013 | $910,000 | – | 38,000 | – | 0.18% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Trigran Investments, Inc. | 1,154,183 | $25,761,000 | 3.00% |
CAPITAL MANAGEMENT CORP /VA | 275,130 | $6,141,000 | 1.52% |
Kent Lake Capital LLC | 98,570 | $2,200,000 | 1.21% |
DIKER MANAGEMENT LLC | 21,835 | $487,000 | 0.60% |
Portolan Capital Management | 235,972 | $5,267,000 | 0.53% |
Riverwater Partners LLC | 12,466 | $278,000 | 0.28% |
Ranger Investment Management | 139,661 | $3,117,000 | 0.24% |
Invenomic Capital Management LP | 144,287 | $3,220,000 | 0.23% |
CHATHAM CAPITAL GROUP, INC. | 23,787 | $531,000 | 0.12% |
Teton Advisors, Inc. | 22,000 | $491,000 | 0.10% |